Table 2. Weighted Prevalence of Clinical Interventions and Outcomes Among a Sample of 25 281 Hospitalized Patients by Race and Ethnicity and Age Group, United States, March 1, 2020, to February 28, 2021.
| Intervention or outcome | Weighted % (95% CI) | ||||||
|---|---|---|---|---|---|---|---|
| Hispanic or Latino | Non-Hispanic | ||||||
| American Indian or Alaska Native | Black | Asian or Pacific Islander | White | ||||
| All ages | |||||||
| ICU admission | 27.2 (25.0-29.4) | 29.2 (21.6-36.7) | 22.9 (20.9-24.9) | 29.7 (24.4-35.1) | 21.1 (19.7-22.5) | ||
| IMV | 17.0 (15.0-19.1) | 16.3 (10.5-22.1) | 12.9 (11.3-14.5) | 17.8 (12.6-23.1) | 10.7 (9.6-11.8) | ||
| Vasopressor use | 15.3 (13.3-17.2) | 15.9 (10.1-21.6) | 12.5 (10.9-14.1) | 17.3 (12.1-22.5) | 10.2 (9.2-11.2) | ||
| Kidney replacement therapy | 5.3 (4.2-6.4) | 7.6 (2.4-12.7) | 9.1 (7.6-10.6) | 3.6 (1.9-5.3) | 4.0 (3.3-4.8) | ||
| In-hospital death | 10.8 (8.8-12.7) | 16.0 (9.6-22.4) | 9.2 (7.8-10.5) | 13.1 (8.2-18.0) | 12.1 (10.9-13.3) | ||
| LOS, median (IQR), d | 4.5 (4.2-4.7) | 5.3 (3.9-6.6) | 4.8 (4.6-5.1) | 4.8 (4.1-5.4) | 4.9 (4.7-5.0) | ||
| <18 y | |||||||
| ICU admission | 23.3 (20.4-26.1) | 32.9 (14.2-51.7) | 33.5 (30.0-37.1) | 22.6 (15.1-30.1) | 25.2 (21.4-28.9) | ||
| IMV | 5.3 (3.8-6.8) | 12.4 (0.0-25.5) | 5.4 (3.7-7.1) | 2.5 (0.0-5.2) | 6.3 (4.2-8.4) | ||
| Vasopressor use | 8.2 (6.3-10.1) | 4.2 (0.0-12.1) | 8.5 (6.4-10.6) | 5.7 (1.6-9.9) | 5.7 (3.7-7.7) | ||
| Kidney replacement therapy | 0.6 (0.1-1.1) | 0 | 0.6 (0.0-1.2) | 0.8 (0.0-2.4) | 0.4 (0.0-0.9) | ||
| In-hospital death | 0.4 (0.0-0.8) | 0 | 1.2 (0.4-2.0) | 0 | 0.6 (0.0-1.2) | ||
| LOS, median (IQR), d | 2.1 (1.9-2.3) | 3.0 (1.7-4.2) | 2.6 (2.4-2.8) | 1.8 (1.5-2.1) | 2.0 (1.8-2.3) | ||
| 18-49 y | |||||||
| ICU admission | 19.5 (17.1-21.9) | 29.0 (20.3-37.7) | 15.7 (12.8-18.5) | 18.2 (12.8-23.7) | 18.4 (15.3-21.5) | ||
| IMV | 10.9 (8.9-13.0) | 14.8 (7.7-22.0) | 7.9 (5.7-10.1) | 6.6 (3.6-9.6) | 8.6 (6.5-10.6) | ||
| Vasopressor use | 9.1 (7.2-10.9) | 14.9 (7.9-21.8) | 7.6 (5.3-9.8) | 6.3 (3.2-9.3) | 6.9 (5.0-8.8) | ||
| Kidney replacement therapy | 3.4 (2.1-4.8) | 8.0 (2.4-13.5) | 5.6 (3.7-7.6) | 3.2 (0.8-5.6) | 2.4 (1.1-3.6) | ||
| In-hospital death | 3.0 (1.9-4.2) | 12.5 (5.3-19.6) | 1.4 (0.7-2.2) | 1.6 (0.2-2.9) | 2.4 (1.2-3.7) | ||
| LOS, median (IQR), d | 3.5 (3.3-3.8) | 4.2 (3.0-5.5) | 3.4 (3.0-3.7) | 3.4 (2.7-4.0) | 3.3 (3.0-3.6) | ||
| 50-64 y | |||||||
| ICU admission | 32.1 (28.1-36.0) | 36.1 (23.9-48.3) | 22.6 (19.6-25.5) | 30.5 (23.3-37.6) | 24.3 (21.6-26.9) | ||
| IMV | 20.0 (16.6-23.5) | 20.0 (11.6-28.4) | 13.7 (11.2-16.1) | 15.3 (9.9-20.8) | 11.9 (9.9-13.9) | ||
| Vasopressor use | 19.3 (15.8-22.8) | 18.7 (10.7-26.6) | 12.7 (10.4-15.1) | 14.9 (9.4-20.3) | 11.7 (9.7-13.7) | ||
| Kidney replacement therapy | 7.6 (5.3-9.9) | 9.5 (0.0-19.9) | 9.3 (7.1-11.4) | 6.9 (2.0-11.9) | 4.9 (3.6-6.2) | ||
| In-hospital death | 10.8 (7.9-13.8) | 13.4 (6.5-20.3) | 7.7 (5.8-9.5) | 8.8 (3.8-13.9) | 7.0 (5.2-8.8) | ||
| LOS, median (IQR), d | 5.4 (4.9-5.9) | 7.1 (5.2-9.1) | 4.8 (4.4-5.1) | 4.6 (3.6-5.5) | 4.5 (4.2-4.7) | ||
| ≥65 y | |||||||
| ICU admission | 35.7 (29.4-41.9) | 25.4 (10.8-40.0) | 28.4 (24.2-32.5) | 35.5 (25.6-45.4) | 20.6 (18.7-22.6) | ||
| IMV | 26.5 (20.2-32.8) | 14.8 (3.2-26.5) | 16.1 (12.9-19.2) | 25.7 (15.7-35.7) | 10.9 (9.4-12.5) | ||
| Vasopressor use | 22.9 (17.1-28.7) | 14.9 (3.3-26.6) | 16.5 (13.2-19.9) | 24.9 (14.9-34.8) | 10.7 (9.2-12.2) | ||
| Kidney replacement therapy | 6.8 (4.2-9.5) | 6.1 (0.0-15.5) | 11.8 (8.7-15.0) | 2.2 (0.1-4.2) | 4.1 (3.0-5.2) | ||
| In-hospital death | 27.2 (21.0-33.5) | 20.6 (6.5-34.7) | 15.9 (12.8-18.9) | 22.1 (12.7-31.4) | 16.2 (14.4-17.9) | ||
| LOS, median (IQR), d | 6.2 (5.1-7.3) | 5.5 (3.1-7.8) | 6.2 (5.5-6.8) | 7.4 (4.8-10.0) | 5.6 (5.3-6.0) | ||
Abbreviations: ICU, intensive care unit; IMV, invasive mechanical ventilation; LOS, length of hospital stay.